Dunn Ranch teams up with RenoVō Allograft for equestrian programs

Equine Amnio Solutions, LLC, a distributor of next-generation regenerative products including the RenoVō equine allograft, has collaborated with Dunn Ranch (Wynnewood and Lexington, Oklahoma).

Mark J. Barrett / stock.adobe.com

According to a company release,¹ Dunn Ranch is renowned around the globe in the stallion and mare services realm including embryo transfers, foaling, breeding management and sales preparation. Positioned on 100 acres with innovative equipment, the Wynnewood and Lexington locations and facilities ensure animal health and comfort. Dunn Ranch leverages RenoVō in the clinical care of their horses and was leading owner during the Remington Park spring meet which concluded May 28, 2022, marking its second consecutive owners' title as leading horsemen.¹

Intended for equine use, RenoVō is an acellular, cryopreserved liquid allograft derived from equine amniotic tissues. Amniotic birth tissues are key sources of bioactive factors involved in tissue regeneration with reported anti-inflammatory, anti-bacterial and anti-fibrotic properties.¹ Reseach has displayed the product is safe and a highly effective alternative to other current modalities in the clinical care of equine injuries. RenoVō is manufactured by Equus Innovations (Phoenix, Arizona) and has been utilized in over 11,000 horses to date.

"RenoVō has been a game-changer for our facility and for our clientele. There is simply no substitute," expressed Bendi Dunn, owner at Dunn Ranch, in the release. Ginger Johnson of EAS added, "We are thrilled to partner with Dunn to support the health of hundreds of horses under their exceptional care."¹

Reference

Dunn Ranch partners with RenoVō Allograft for equestrian programs. News release. Equine Amnio Solutions, LLC. August 29, 2022. Accessed August 31, 2022. https://www.prnewswire.com/news-releases/dunn-ranch-partners-with-renov-allograft-for-equestrian-programs-301613365.html